Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Intangibles (2019 - 2026)

Immatics (IMTX) posted Intangibles of $1.8 million for Q4 2025, up 0.91% sequentially from $1.8 million in Q3 2025, and up 5.79% YoY from $1.7 million in Q4 2024.

Analysis

Immatics (IMTX) Intangibles (2019 - 2026) Analysis & Trends

Immatics has reported Intangibles for 7 years, with the latest figure at $1.8 million in Q4 2025.

  • Quarterly Intangibles rose 5.79% year-over-year to $1.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.8 million (up 5.79% YoY) and the FY2025 annual result came in at $1.8 million, up 1.37% from the prior year.
  • Intangibles climbed to $1.8 million in Q4 2025 per IMTX's latest filing, from $1.8 million in the prior quarter.
  • Over five years, Intangibles peaked at $3.3 million in Q4 2023 and troughed at $1.1 million in Q1 2021.
  • A 5-year average of $1.7 million and a median of $1.7 million in 2023 frame the typical range for Intangibles.
  • The sharpest annual moves came in 2023 and 2024: Intangibles soared 101.1% in 2023, then tumbled 48.01% in 2024.
  • Over 5 years, Intangibles stood at $1.5 million in 2021, then climbed by 10.68% to $1.7 million in 2022, then surged by 101.1% to $3.3 million in 2023, then sank by 48.01% to $1.7 million in 2024, then advanced by 5.79% to $1.8 million in 2025.
  • According to Business Quant data, Intangibles over the past three periods registered $1.8 million, $1.8 million, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 412.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 266.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 63.28 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 60.96 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 93.49 Mn
10 Immatics 1.17 Bn 711.21 Mn - 1.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.82 Mn
Mar 31, 2026 1.85 Mn
Dec 31, 2025 1.84 Mn
Sep 30, 2025 1.82 Mn
Jun 30, 2025 1.81 Mn
Mar 31, 2025 1.68 Mn
Dec 31, 2024 1.74 Mn
Sep 30, 2024 1.65 Mn
Jun 30, 2024 1.73 Mn
Mar 31, 2024 1.63 Mn
Dec 31, 2023 1.64 Mn
Sep 30, 2023 1.78 Mn
Jun 30, 2023 1.80 Mn
Mar 31, 2023 1.68 Mn
Dec 31, 2022 1.67 Mn
Sep 30, 2022 1.55 Mn
Jun 30, 2022 1.40 Mn
Mar 31, 2022 1.44 Mn
Dec 31, 2021 1.50 Mn
Sep 30, 2021 1.51 Mn